Thermo Fisher Scientific Inc.. (10/1/09). "Press Release: Thermo Fisher Scientific Completes B.R.A.H.M.S Acquisition". Waltham, MA.

	Region	Hennigsdorf
	Country	Germany
	Organisation	BRAHMS Holding GmbH
	Group	Thermo Fisher (Group)
	Organisation 2	Thermo Fisher Scientific Inc. (NYSE: TMO)
	Group	Thermo Fisher (Group)
	Product	in vitro diagnostics (IVD)
	Index term	BRAHMS–Thermo Fisher: investment, 200909–200910 acquisition €330m incl debt + other liabilities

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed its previously announced acquisition of B.R.A.H.M.S. AG for €330 million (approximately $470 million USD). B.R.A.H.M.S. generated 2008 revenues of €75 million (approximately $105 million USD), and is expected to be accretive to adjusted earnings per share in 2010. Thermo Fisher will integrate B.R.A.H.M.S. into its Analytical Technologies Segment, and plans to use the firm's former headquarters in Hennigsdorf, Germany, as the European Center of Excellence for its clinical diagnostics business.

Best known today for its flagship test, Procalcitonin (PCT), B.R.A.H.M.S is a leading provider of specialty in-vitro diagnostic tests based on patented biomarkers for sepsis, cardiovascular and pulmonary diseases, as well as intensive care treatments and prenatal screening.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With 2008 revenues of $10.5 billion, we have approximately 34,000 employees and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, we help solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, we offer the most convenient purchasing options to customers and continuously advance our technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike. Visit www.thermofisher.com.

The following constitutes a "Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995: This press release contains forward-looking statements that involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in the Company's Quarterly Report on Form 10-Q for the period ended June 27, 2009, under the caption "Risk Factors," which is on file with the Securities and Exchange Commission and available in the "Investors" section of our Website under the heading "SEC Filings." Important factors that could cause actual results to differ materially from those indicated by forward-looking statements include risks and uncertainties relating to: competition and its effect on pricing, spending, third-party relationships and revenues; the need to develop new products and adapt to significant technological change; implementation of strategies for improving internal growth; general worldwide economic conditions and related uncertainties; dependence on customers' capital spending policies and government funding policies; the effect of exchange rate fluctuations on international operations; use and protection of intellectual property; the effect of changes in governmental regulations; the effect of laws and regulations governing government contracts; the effect of competing with certain of our customers and suppliers; and the effect of rapid changes in the healthcare industry. While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, even if our estimates change and, therefore, you should not rely on these forward-looking statements as representing our views as of any date subsequent to today.

Thermo Fisher Scientific Inc.
Media Contact:
Karen Kirkwood, 781-622-1306
karen.kirkwood@thermofisher.com
www.thermofisher.com
or
Investor Contact:
Ken Apicerno, 781-622-1111
ken.apicerno@thermofisher.com

Record changed: 2011-11-25

Follow Us!

Top News

Upcoming Events

Associations

Partners

Thermo Fisher Scientific Inc.. (10/1/09). "Press Release: Thermo Fisher Scientific Completes B.R.A.H.M.S Acquisition". Waltham, MA.

More documents for Thermo Fisher (Group)